Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Saxon

Interventional Cardiology Charlottesville, VA Medical Doctor

NPI 1790948271 CMS profile 217687

1221 Lee Street, Charlottesville, VA 22908

Open in the dashboard

General payments

$115,609

205 records reported · program years 2019–2025

Research payments

$2,000

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$784,549 paid to institutions, not to them · program years 2021–2025

Through program year 2025, John Saxon of Charlottesville, VA is reported in the CMS Open Payments database as having received $115,609 across 205 general payments and $2,000 in research payments paid to them. Separately, studies naming them as principal investigator received $784,549 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 92nd percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $46,844 55
2024 General $26,534 38
2023 General $15,697 41
2023 Research $2,000 1
2022 General $1,225 18
2021 General $5,381 12
2020 General $16,115 16
2019 General $3,811 25

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Saxon
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to John Saxon were reported at $46,844. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year John Saxon Interventional Cardiology median Middle half National median
2019 $3,811 $1,097 $329–$3,048 $163
2020 $16,115 $473 $161–$1,480 $114
2021 $5,381 $677 $233–$1,827 $132
2022 $1,225 $978 $333–$2,724 $149
2023 $15,697 $1,136 $382–$2,986 $160
2024 $26,534 $1,181 $395–$3,326 $164
2025 $46,844 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Edwards Lifesciences Corporation $46,971 52 payments
  2. Abbott Laboratories $33,580 63 payments
  3. Medtronic, Inc. $22,570 54 payments
  4. Biosense Webster, Inc. $5,874 6 payments
  5. Medtronic Vascular, Inc. $2,294 8 payments
  6. Ancora Heart, Inc. $1,707 5 payments
  7. W. L. Gore & Associates, Inc. $1,577 3 payments
  8. Boston Scientific Corporation $753 11 payments
  9. Cardiac Dimensions, Inc. $246 1 payment
  10. Abiomed $31 1 payment
  11. Other $4 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $68,866 20 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $18,528 5 payments
  3. Travel and Lodging $17,864 48 payments
  4. Food and Beverage $8,351 131 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $2,000 1 payment
Products named General payments · program years 2019–2025
  1. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $33,610 13 payments
  2. COREVALVE EVOLUT R $20,685 33 payments
  3. AMPLATZER Occluders $16,604 14 payments
  4. AMPLATZER AMULET $7,500 3 payments
  5. PASCAL $7,063 12 payments
  6. Carto 3 $5,761 5 payments
  7. AMPLATZER Vascular Plug and Accs $4,038 1 payment
  8. NAVITOR $3,049 8 payments
  9. AccuCinch $1,707 5 payments
  10. Product in Development $1,560 2 payments
  11. Other $5,286 82 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $2,000 1 payment

Billing to Medicare

Part B · data year 2024 · 48 billing codes

Paid by Medicare

$117,269

Medicare's payments for the services billed

Medicare patients

489

Average age 76

Services billed

752

231 women, 258 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 56%
Heart failure 53%
Atrial fibrillation 50%
Arthritis 42%
Chronic kidney disease 37%
Diabetes 31%
Depression 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

206 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record